Denali Therapeutics Inc. DNLI

DNLI

Denali Therapeutics Inc.

Exchange: nyse

Multiples

P/E: -7.94
P/BV: 2.57
P/TBV: 3.29

Description:

none

Data:

Market Cap

3393680640.00

EBITDA

-511854016.00

Net Income

Yields:

Earnings Yield

0.652882554856

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate